Martin Nicholas to Infusions, Intravenous
This is a "connection" page, showing publications Martin Nicholas has written about Infusions, Intravenous.
Connection Strength
0.032
-
A phase I study of continuous infusion cilengitide in patients with solid tumors. Invest New Drugs. 2012 Apr; 30(2):604-10.
Score: 0.022
-
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies. Clin Cancer Res. 1999 Jun; 5(6):1325-30.
Score: 0.010